Adcock Ingram Holdings Limited
Adcock Ingram Holdings Limited (AIHLF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
aihlf · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Adcock Ingram Holdings Limited (AIHLF) measures how much investors pay for each dollar of the company's trailing earnings. AIHLF's current PE ratio of 12.79x is calculated by dividing its stock price of $3.50 by its TTM earnings per share of $5.85. +23.1% elevated vs 5Y avg 10.4x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%10.6x
MedianQ3 · 75%62.5x
Max
At 12.79x, AIHLF's current P/E is within its average historical range over the past 19 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Adcock Ingram Holdings LimitedYou AIHLF | $624M | 12.79x | +359.7% | $5.85 |
 Columbia Care Inc. CCHWF | $521M | N/A | — | -$0.26 |
 Opthea Limited CKDXF | $602M | N/A | — | -$0.13 |
 Claritas Pharmaceuticals, Inc. CLAZF | $0M | 0.00x | -99.9% | $0.16 |
 China Shineway Pharmaceutical Group Limited CSWYF | $816M | 5.56x | +99.9% | $1.26 |
 Inventiva S.A. IVEVF | $556M | N/A | — | -$1.90 |
 Kindstar Globalgene Technology, Inc. KDGTF | $675M | N/A | — | — |
Industry Average 2 peers with valid PE | — | 2.78x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | 7.40x | $5.85 | -9.9% | |
2024-06-30 FY2024 | 8.21x | $5.40 | -22.0% | |
2023-06-30 FY2023 | 10.52x | $5.61 | +1.9% | |
2022-06-30 FY2022 | 10.32x | $4.95 | -33.5% | |
2021-06-30 FY2021 | 15.51x | $3.96 | -17.3% | |
2020-06-30 FY2020 | 18.76x | $3.98 | +27.5% | |
2019-06-30 FY2019 | 14.72x | $4.14 | -4.5% | |
2018-06-30 FY2018 | 15.42x | $3.84 | -8.8% | |
2017-06-30 FY2017 | 16.91x | $3.33 | -73.0% | |
2016-06-30 FY2016 | 62.54x | $1.01 | +39.8% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Adcock Ingram Holdings Limited (AIHLF) measures how much investors pay for each dollar of the company's trailing earnings. AIHLF's current PE ratio of 12.79x is calculated by dividing its stock price of $3.50 by its TTM earnings per share of $5.85.
Frequently asked questions
AIHLF pe ratio · 6 questionsAIHLF's current PE ratio is 12.79x as of 2026-06-09, based on a stock price of $3.50 and TTM EPS of $5.85. Data sourced from Financial Modeling Prep via AIHLF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Adcock Ingram Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09